• Japanese
  • Korean
  • Chinese
Cover Image

Bacterial (Pyogenic) Meningitis Global Clinical Trials Review, H2, 2014

GlobalData's clinical trial report, "Bacterial (Pyogenic) Meningitis Global Clinical Trials Review, H2, 2014" provides data on the Bacterial (Pyogenic) Meningitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bacterial (Pyogenic) Meningitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bacterial (Pyogenic) Meningitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 4
  • List of Figures 5
  • Introduction 6
  • Bacterial (Pyogenic) Meningitis 6
  • Report Guidance 6
  • Clinical Trials by Region 7
  • Clinical Trials and Average Enrollment by Country 8
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
  • Top Five Countries Contributing to Clinical Trials in Europe 11
  • Top Countries Contributing to Clinical Trials in North America 12
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
  • Top Five Countries Contributing to Clinical Trials in Central and South America 14
  • Clinical Trials by G7 Countries: Proportion of Bacterial (Pyogenic) Meningitis to Infectious Disease Clinical Trials 15
  • Clinical Trials by Phase in G7 Countries 16
  • Clinical Trials in G7 Countries by Trial Status 17
  • Clinical Trials by E7 Countries: Proportion of Bacterial (Pyogenic) Meningitis to Infectious Disease Clinical Trials 18
  • Clinical Trials by Phase in E7 Countries 19
  • Clinical Trials in E7 Countries by Trial Status 20
  • Clinical Trials by Phase 21
  • In Progress Trials by Phase 22
  • Clinical Trials by Trial Status 23
  • Clinical Trials by End Point Status 24
  • Unaccomplished Trials of Bacterial (Pyogenic) Meningitis 25
  • Subjects Recruited Over a Period of Time 27
  • Clinical Trials by Sponsor Type 28
  • Prominent Sponsors 29
  • Top Companies Participating in Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials 30
  • Prominent Drugs 32
  • Clinical Trial Profiles 33
  • Clinical Trial Overview of Top Companies 33
  • Novartis AG 33
  • Clinical Trial Overview of Novartis AG 33
  • Pfizer Inc. 37
  • Clinical Trial Overview of Pfizer Inc. 37
  • GlaxoSmithKline plc 40
  • Clinical Trial Overview of GlaxoSmithKline plc 40
  • Sanofi 42
  • Clinical Trial Overview of Sanofi 42
  • Serum Institute of India Limited 43
  • Clinical Trial Overview of Serum Institute of India Limited 43
  • Baxter International Inc. 44
  • Clinical Trial Overview of Baxter International Inc. 44
  • JN-International Medical Corporation 45
  • Clinical Trial Overview of JN-International Medical Corporation 45
  • Beijing Minhai Biotechnology Co., Ltd 46
  • Clinical Trial Overview of Beijing Minhai Biotechnology Co., Ltd 46
  • Abbott Laboratories 47
  • Clinical Trial Overview of Abbott Laboratories 47
  • Clinical Trial Overview of Top Institutes / Government 48
  • University of Oxford 48
  • Clinical Trial Overview of University of Oxford 48
  • Assistance Publique - Hopitaux de Paris 49
  • Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 49
  • Universitas Padjadjaran 50
  • Clinical Trial Overview of Universitas Padjadjaran 50
  • Chhatrapati Shahuji Maharaj Medical University 51
  • Clinical Trial Overview of Chhatrapati Shahuji Maharaj Medical University 51
  • Health Protection Agency 52
  • Clinical Trial Overview of Health Protection Agency 52
  • The National Institute of Allergy and Infectious Diseases 53
  • Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 53
  • Bio-Manguinhos 54
  • Clinical Trial Overview of Bio-Manguinhos 54
  • University of Malawi 55
  • Clinical Trial Overview of University of Malawi 55
  • National Institute for Public Health and the Environment 56
  • Clinical Trial Overview of National Institute for Public Health and the Environment 56
  • Epicentre Biotechnologies 57
  • Clinical Trial Overview of Epicentre Biotechnologies 57
  • Five Key Clinical Profiles 58

Appendix 98

  • Abbreviations 98
  • Definitions 98
  • Research Methodology 99
  • Secondary Research 99
  • About GlobalData 100
  • Contact Us 100
  • Disclaimer 100
  • Source 100

List of Tables

List of Tables

  • Bacterial (Pyogenic) Meningitis Therapeutics, Global, Clinical Trials by Region, 2014* 7
  • Bacterial (Pyogenic) Meningitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
  • Bacterial (Pyogenic) Meningitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
  • Proportion of Bacterial (Pyogenic) Meningitis to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15
  • Bacterial (Pyogenic) Meningitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
  • Bacterial (Pyogenic) Meningitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
  • Proportion of Bacterial (Pyogenic) Meningitis to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18
  • Bacterial (Pyogenic) Meningitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
  • Bacterial (Pyogenic) Meningitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
  • Bacterial (Pyogenic) Meningitis Therapeutics, Global, Clinical Trials by Phase, 2014* 21
  • Bacterial (Pyogenic) Meningitis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
  • Bacterial (Pyogenic) Meningitis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
  • Bacterial (Pyogenic) Meningitis Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
  • Bacterial (Pyogenic) Meningitis Therapeutics, Global, Terminated Clinical Trials, 2014* 26
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
  • Bacterial (Pyogenic) Meningitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 33
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 37
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 40
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 42
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Serum Institute of India Limited, 2014* 43
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter International Inc., 2014* 44
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by JN-International Medical Corporation, 2014* 45
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Beijing Minhai Biotechnology Co., Ltd, 2014* 46
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2014* 47
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2014* 48
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014* 49
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Universitas Padjadjaran, 2014* 50
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Chhatrapati Shahuji Maharaj Medical University, 2014* 51
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Health Protection Agency, 2014* 52
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 53
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bio-Manguinhos, 2014* 54
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Malawi, 2014* 55
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute for Public Health and the Environment, 2014* 56
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Epicentre Biotechnologies, 2014* 57

List of Figures

List of Figures

  • Bacterial (Pyogenic) Meningitis Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
  • Bacterial (Pyogenic) Meningitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
  • Bacterial (Pyogenic) Meningitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
  • Proportion of Bacterial (Pyogenic) Meningitis to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15
  • Bacterial (Pyogenic) Meningitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
  • Bacterial (Pyogenic) Meningitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
  • Proportion of Bacterial (Pyogenic) Meningitis to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18
  • Bacterial (Pyogenic) Meningitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
  • Bacterial (Pyogenic) Meningitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
  • Bacterial (Pyogenic) Meningitis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
  • Bacterial (Pyogenic) Meningitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
  • Bacterial (Pyogenic) Meningitis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
  • Bacterial (Pyogenic) Meningitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
  • GlobalData Methodology 99
Show More
Pricing